No Draft Red Herring Prospectus (DRHP) or Red Herring Prospectus (RHP) has been officially filed with SEBI by Quanto Agroworld Limited as of late May 2024, indicating it is not yet in the active public offering process.16 September 2026SME IPO - BSE SME · 7 min read

Quanto Agroworld Limited — Pre-IPO Research Report

Quanto Agroworld Limited, established in 2018, operates in the agro products sector, focusing on the cultivation, processing, and supply of Medicinal and Aromatic Plants (MAPs) in India. Its primary commercial focus is lemongrass, positioning it within a niche agricultural segment with potential for value-added products.

Founded

2018

Headquarters

Not officially disclosed in public filings

Sector

Agro Products (Medicinal and Aromatic Plants)

Primary Crop Focus

Lemongrass

Total Revenue (Latest Fiscal Year)

Not officially disclosed; refer to future DRHP/RHP

Profit After Tax (Latest Fiscal Year)

Not officially disclosed; refer to future DRHP/RHP

What the company is (and how it makes money)

Engaged in the cultivation of Medicinal and Aromatic Plants (MAPs) on Indian soil.
Primarily focuses on lemongrass cultivation, which is a key raw material for essential oils and other derivatives.
Involves processing of harvested MAPs, likely for extraction of essential oils or other value-added products.
Supplies processed agro products to various industries, potentially including pharmaceuticals, cosmetics, and food & beverage.
Operates within the broader agricultural sector, with a specific emphasis on high-value botanical extracts.

Financial snapshot (officially disclosed only)

The company's detailed financial performance, including revenue, profit, and cash flow statements, has not been officially disclosed via a SEBI DRHP/RHP or stock exchange filings.
Investors should scrutinize the company's audited financial statements, particularly revenue growth, profitability margins, and working capital cycles, once a DRHP/RHP is filed.
Key metrics to look for will include gross margins on MAP cultivation and processing, and the proportion of revenue derived from value-added products versus raw material supply.
Details on asset base, particularly land holdings (owned vs. leased) and processing infrastructure, will be crucial for understanding operational scale and capital intensity.

The moat

Specialization in specific MAPs like lemongrass could create a niche, provided there's proprietary knowledge in cultivation techniques or processing for higher yield/quality.
Integrated operations from cultivation to processing might offer better quality control and supply chain reliability compared to sourcing from multiple fragmented growers.
Potential long-term contracts with industrial buyers for essential oils or extracts could provide demand stability, though this needs verification.
Expertise in sustainable or organic farming practices for MAPs could command a premium in certain markets, if certified and documented.
Access to specific land parcels suitable for MAP cultivation, coupled with necessary agricultural infrastructure, could be a barrier to entry for new players.

Where it is in the IPO pipeline

As of late May 2024, Quanto Agroworld Limited has not filed a Draft Red Herring Prospectus (DRHP) with SEBI.
An IPO cannot proceed without the submission and approval of a DRHP and subsequently an RHP by SEBI.
The company would need to outline its proposed issue size, whether it's a fresh issue of shares (for capital expenditure or working capital) or an Offer For Sale (OFS) by existing shareholders, or a combination.
Given its likely SME status, the IPO would typically involve a smaller issue size and list on the BSE SME platform, subject to SEBI and exchange approvals.
The timeline for an IPO is contingent on filing a DRHP, SEBI's review process, and market conditions, none of which are currently established.

What most investors miss

**Specifics of Land Holdings & Cultivation:** Generic coverage often misses whether the company owns, leases, or engages in contract farming for its land. Each model carries different risks (e.g., lease expiry, farmer dependency, land title issues).
**Processing Infrastructure & Certifications:** For 'Medicinal and Aromatic Plants', the quality and regulatory compliance of processing units (e.g., distillation plants for essential oils) and necessary certifications (e.g., GMP, organic) are critical and often overlooked.
**Customer Concentration & Offtake Agreements:** Understanding who the primary buyers are, the nature of their contracts (long-term vs. spot), and potential concentration risk is vital, especially for a niche supplier.
**Seasonality & Weather Dependency:** Agricultural businesses are inherently cyclical and highly dependent on monsoons and weather patterns. The company's strategies for mitigating these risks (e.g., irrigation, crop diversification) need deep scrutiny.
**Regulatory Landscape for MAPs:** The regulatory environment for medicinal plant cultivation, processing, and sale (e.g., AYUSH Ministry guidelines, FSSAI norms for extracts, export regulations) can be complex and impact scalability and market access.
**Working Capital Management in Agriculture:** Agricultural cycles often involve significant upfront investment in cultivation with delayed realization of revenue. The company's working capital needs and financing structure will be a key determinant of financial health.

Red flags and what to scrutinise

**Commodity Price Volatility:** The prices of agricultural commodities, including lemongrass and its derivatives, can be highly volatile due to supply-demand dynamics, weather, and global market trends, impacting revenue and profitability.
**Climate Change & Environmental Risks:** Increased frequency of extreme weather events (droughts, floods) poses a significant threat to agricultural yields and operational continuity.
**Dependence on a Single Crop:** A primary focus on lemongrass exposes the company to specific crop-related risks (pests, diseases, market shifts for that particular plant), without the buffer of broader crop diversification.
**Scalability Challenges in Agriculture:** Expanding cultivation and processing often requires significant capital expenditure, land acquisition, and skilled labor, which can be difficult and slow to scale.
**Quality Control & Contamination Risks:** For medicinal plants, maintaining strict quality control and preventing contamination (pesticides, heavy metals) throughout the cultivation and processing chain is paramount; failure can lead to product recalls and reputational damage.
**SME IPO Liquidity & Governance:** As a potential SME listing, liquidity in the secondary market can be lower, and governance structures in smaller, unlisted companies sometimes warrant closer examination for related-party transactions or promoter guarantees.

How to evaluate it (a diligence checklist)

Examine the company's land acquisition or leasing agreements, assessing their long-term viability, costs, and any associated encumbrances.
Scrutinise the details of its cultivation practices, including irrigation methods, pest management, and any certifications (e.g., organic, GAP) to understand quality and sustainability.
Review the processing infrastructure, its capacity utilization, technological capabilities, and adherence to relevant industry standards and regulatory compliance for MAPs.
Analyze customer contracts, distribution channels, and sales pipeline to understand revenue predictability, customer concentration, and market reach.
Evaluate the company's management team's experience in agriculture, specifically MAPs, and their track record in scaling operations and navigating market cycles.
Assess the company's capital allocation strategy, particularly how it plans to fund future growth, manage working capital, and invest in R&D for new plant varieties or value-added products.

Official references

SEBI - Draft offer documents & public issues SEBI - Securities and Exchange Board of India NSE India - listings & filings BSE India - listings & filings MCA - company master data & financial filings

The company DRHP on the SEBI website (when filed)
Ministry of Corporate Affairs (MCA) filings for Quanto Agroworld Limited
Reports from the National Medicinal Plants Board (NMPB) on the MAPs sector in India
Agricultural & Processed Food Products Export Development Authority (APEDA) guidelines for agro-product exports

Frequently asked questions

What kind of products does Quanto Agroworld Limited primarily deal in?

The company primarily focuses on the cultivation, processing, and supply of Medicinal and Aromatic Plants (MAPs), with lemongrass being its principal commercial focus. This typically involves producing essential oils, extracts, or raw plant material.

Has Quanto Agroworld Limited filed for an IPO?

As of late May 2024, Quanto Agroworld Limited has not officially filed a Draft Red Herring Prospectus (DRHP) with SEBI, which is a prerequisite for launching an IPO.

What are the main agricultural risks for the company?

Key agricultural risks include dependency on monsoon and weather patterns, potential for pests and diseases affecting crop yields, and the inherent volatility of commodity prices for agricultural produce and their derivatives.

How does the company ensure quality for medicinal plants?

Ensuring quality for medicinal plants typically involves controlled cultivation practices, adherence to Good Agricultural Practices (GAP), rigorous post-harvest handling, and quality checks during the processing stage. Specific certifications (e.g., organic, GMP) would confirm adherence to certain standards.

What are the regulatory considerations for MAPs in India?

The cultivation, processing, and sale of Medicinal and Aromatic Plants in India can be subject to regulations from bodies like the AYUSH Ministry, the Food Safety and Standards Authority of India (FSSAI) for extracts, and export-import policies if products are traded internationally.

What is the typical business model for such an agro-company?

The business model often involves cultivating specific MAPs, processing them into value-added products (like essential oils, extracts), and then supplying these to industrial clients in sectors such as pharmaceuticals, cosmetics, or food and beverages.

This report is prepared by Neoma Capital for information and investor-education purposes only. It is not investment advice, a recommendation, or an offer to buy or sell any security. Unlisted and pre-IPO shares are illiquid, high-risk and may never list. Any figures mentioned are only those officially disclosed by the company, SEBI, the stock exchanges or the MCA, and may change. Neoma Capital does not guarantee accuracy or completeness. Verify everything independently from official sources and consult a SEBI-registered adviser before making any decision. Neoma Capital, 16 September 2026.